McKesson Corp and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health for about $5.8 billion, paying $32.05 per share, a 37% premium. CD&R will own 51% and McKesson 49% with McKesson investing $1.4 billion for its stake. Option Care Health, a leading US home and alternate-site infusion service provider, will remain independent with its current management. The deal supports McKesson's strategy to expand specialty care access outside traditional settings and is expected to close in early 2027 after approvals. Option Care's shares surged over 30% on the news, and it will be delisted from Nasdaq post-acquisition.
McKesson Corporation shares trade at USD 919.78 on Pluang as of Oct 06, 2026 21:32 WIB, up 0.47% in the last day. The company has a market cap of $106.73 billion and an enterprise value of $113.27 billion. Despite the acquisition news of Option Care Health, Pluang investors show a 61% sell and 39% buy order activity for McKesson, indicating mixed sentiment.
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
The U.S. Supreme Court is considering whether a climate change lawsuit by Boulder County against Exxon and Suncor can proceed in state court, with potential nationwide impact. Meanwhile, Mattel faces activist investor pressure to explore strategic op...
